KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q3 2025 value amounting to 0.02.

  • CRISPR Therapeutics AG's Asset Utilization Ratio fell 7967.98% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 7967.98%. This contributed to the annual value of 0.02 for FY2024, which is 8994.56% down from last year.
  • CRISPR Therapeutics AG's Asset Utilization Ratio amounted to 0.02 in Q3 2025, which was down 7967.98% from 0.02 recorded in Q2 2025.
  • CRISPR Therapeutics AG's 5-year Asset Utilization Ratio high stood at 0.37 for Q2 2021, and its period low was 0.0 during Q4 2022.
  • Its 5-year average for Asset Utilization Ratio is 0.11, with a median of 0.08 in 2023.
  • As far as peak fluctuations go, CRISPR Therapeutics AG's Asset Utilization Ratio surged by 7554113.33% in 2021, and later plummeted by 9984.12% in 2022.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Asset Utilization Ratio stood at 0.33 in 2021, then plummeted by 99.84% to 0.0 in 2022, then skyrocketed by 32895.55% to 0.17 in 2023, then crashed by 90.35% to 0.02 in 2024, then rose by 8.1% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.02 for Q2 2025, and 0.02 during Q1 2025.